U.S. STOCKS Eli Lilly, JD.com, Super Micro Computer
Eikon search string for individual stock moves: STXBZ
The Day Ahead newsletter: https://refini.tv/3LI4BU7
The Morning News Call newsletter: https://refini.tv/3dKUyB8
Wall Street's main indexes were lower on Tuesday, weighed down by tech-related stocks, as caution prevailed ahead of a highly anticipated earnings report from Nvidia and crucial economic data expected later in the week. .N
At 11:41 ET, the Dow Jones Industrial Average .DJI was down 0.25% at 41,137.9. The S&P 500 .SPX was down 0.07% at 5,612.98 and the Nasdaq Composite .IXIC was down 0.11% at 17,706.13.
The top three S&P 500 .PG.INX percentage gainers:
** Insulet Corp PODD.O, up 7.3%
** Resmed Inc RMD.N, up 5.9%
** Align Technology Inc ALGN.O, up 2.5%
The top three S&P 500 .PL.INX percentage losers:
** Paramount Global PARA.O, down 5.3%
** Walgreen Boots Alliance Inc WBA.O, down 4.8%
** Martin Marietta Materials Inc MLM.N, down 4.6%
The top three NYSE .PG.N percentage gainers:
** ProShares UltraShort Ether ETF ETHD.N, up 12%
** North European Oil Royalty Trust NRT.N, up 7%
** Energizer Holdings Inc ENR.N, up 6.5%
The top three NYSE .PL.N percentage losers:
** Gaotu Techedu Inc GOTU.N, down 14.7%
** AdvisorShares Pure US Cannabis ETF MSOS.N, down 12%
** Lumen Technologies Inc LUMN.N, down 10.5%
The top three Nasdaq .PG.O percentage gainers:
** VOXX International Corp VOXX.O, up 60.2%
** Trinity Biotech PLC TRIB.O, up 45.8%
** Addex Therapeutics Ltd ADXN.O, up 43.6%
The top three Nasdaq .PL.O percentage losers:
** Cosciens Biopharma Inc CSCI.O, down 33.8%
** Lifecore Biomedical Inc LFCR.O, down 21.4%
** Bolt Projects Holdings Inc BSLK.O, down 17.8%
** Paramount Global PARA.O: down 5.2%
BUZZ - Slides as Edgar Bronfman abandons bid nL4N3KE0K0
** Gaotu Techedu Inc GOTU.N: down 14.7%
BUZZ - Falls after posting Q2 loss nL4N3KE0OF
** Trip.com Group Ltd TCOM.O: up 9.7% premarket
BUZZ - Rises after Q2 results nL4N3KE0RP
** Hershey Co HSY.N: down 1.8%
BUZZ - Falls as Citi downgrades to 'sell' on cocoa inflation, weak demand nL4N3KE0TN
** Trinity Biotech PLC TRIB.O: up 45.8%
BUZZ - Rises after raising sales forecast for HIV test nL4N3KE0TP
** Cava Group Inc CAVA.N: down 5.8%
BUZZ - To ease from post-IPO record high as execs, top holder sell shares nL4N3KE0X0
** Insulet Corp PODD.O: up 7.4%
BUZZ - Jumps after FDA clears expanded use of insulin delivery system nL4N3KE17W
** Coinbase Global Inc COIN.O: down 4.3%
** Bitfarms Ltd BITF.O: down 5.9%
** Riot Platforms Inc RIOT.O: down 6.3%
** Hut 8 Mining Corp HUT.O: down 8.1%
BUZZ - Crypto shares down on bitcoin weakness nL4N3KE0YP
** Cosciens Biopharma Inc CSCI.O: down 33.8%
BUZZ - Slides on trial failure of growth hormone deficiency diagnostic drug nL4N3KE0XL
** Ensysce Bioscience Inc ENSC.O: up 38.8%
BUZZ - Rises on US government grant for its pain relief drug nL4N3KE0YO
** PDD Holdings Inc PDD.O: down 3.9%
BUZZ - ADRs ease as Citi downgrades to 'neutral' following record slump nL4N3KE0ZQ
** SNDL Inc SNDL.O: down 4.3%
** Organigram Holdings Inc OGI.O: down 7.0%
** Tilray Brands Inc TLRY.O: down 5.4%
** Cronos Group Inc CRON.O: down 4.1%
BUZZ - Pot stocks fall as US drug agency to hold reclassification hearing after elections nL4N3KE10J
** Leslie's Inc LESL.O: down 9.9%
BUZZ - Slides after announcing CEO transition nL1N3KE0IG
** JD.com Inc JD.O: up 2.8%
BUZZ - Jumps on buyback plan nL4N3KE14K
** First Busey Corp BUSE.O: down 2.1%
BUZZ - Dips after CrossFirst deal nL4N3KE14P
** Hims & Hers Health Inc HIMS.N: down 7.4%
** LifeMD Inc LFMD.O: down 7.9%
** Teladoc Health Inc TDOC.N: down 2.4%
BUZZ - Telehealth firms fall after Lilly launches single-dose vials of weight-loss drug nL4N3KE10Q
** Eli Lilly and Co LLY.N: up 0.8%
BUZZ - Rises after launching single-dose vials of weight-loss drug for $399 nL4N3KE15K
** Super Micro Computer Inc SMCI.O: down 3.2%
BUZZ - Drops after Hindenburg discloses short position nL4N3KE154
** Lumen Technologies Inc LUMN.N: down 10.5%
BUZZ - Slides after Kerrisdale discloses short position nL4N3KE16T
** Cleveland-Cliffs Inc CLF.N: up 0.7%
BUZZ - Edges higher after Seaport Research upgrades to "buy" nL4N3KE17T
** Soleno Therapeutics Inc SLNO.O: up 4.1%
BUZZ - Rises as FDA grants priority review for genetic disorder treatment nL4N3KE17U
** BILL Holdings Inc BILL.N: up 6.2%
BUZZ - Jumps after top executives buy stake nL4N3I4347
The 11 major S&P 500 sectors:
Communication Services | .SPLRCL | down 0.02% |
Consumer Discretionary | .SPLRCD | down 0.74% |
Consumer Staples | .SPLRCS | up 0.15% |
Energy | .SPNY | down 0.68% |
Financial | .SPSY | up 0.28% |
Health | .SPXHC | down 0.17% |
Industrial | .SPLRCI | down 0.25% |
Information Technology | .SPLRCT | up 0.17% |
Materials | .SPLRCM | down 0.43% |
Real Estate | .SPLRCR | down 0.05% |
Utilities | .SPLRCU | down 0.68% |
(Compiled by Rajarshi Roy and Pooja Menon in Bengaluru)
</body></html>Related Assets
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
